Stock listing
Tradegate:CUP Chugai Pharmaceutical Co., Ltd. Aktie
German listing (Tradegate) of Chugai Pharmaceutical Co., Ltd. · home listing Tokyo:4519
Follow Chugai Pharmaceutical Co., Ltd. into a list and get an email when it puts out news.
Home listing price · TSE:4519
¥7,109.00 JPY -157.00 (-2.2%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, TSE:4519 · Price from Kabutan
- Day range
- ¥7,109.00 – ¥7,288.00 JPYNov 20, 2026
- Volume
- 2.62M sharesNov 20, 2026
- Market cap
- ¥11.94T JPYAt the close on Nov 20, 2026 · price × 1.68B shares outstanding
- Traded on an average day
- ¥19.86B JPYMedian day 2.73M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| OTC:CHGCY | $22.26 USD | -0.20 (-0.9%) | 218,409 | $22.81 | $22.81 | $22.01 | $22.46 | Close on Nov 20, 2026 |
| OTC:CHGCF | $44.81 USD | +0.488 (+1.1%) | 561 | $44.81 | $44.81 | $44.81 | $44.32 | Close on Nov 20, 2026 |
| Frankfurt:CUP | €40.51 EUR | -0.67 (-1.6%) | — | €40.54 | €40.65 | €40.51 | €41.18 | Close on Nov 20, 2026 |
| Munich:CUP | €40.08 EUR | -1.67 (-4.0%) | — | €40.64 | €40.64 | €40.08 | €41.75 | Close on Nov 20, 2026 |
| Dusseldorf:CUP | €39.61 EUR | -1.17 (-2.9%) | — | €40.09 | €40.58 | €39.61 | €40.78 | Close on Nov 20, 2026 |
| Frankfurt:CUP0 | €19.50 EUR | -0.40 (-2.0%) | — | €19.50 | €19.50 | €19.50 | €19.90 | Close on Nov 19, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TSE:4519 · JPY, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ¥7,109.00 | -157.00 | -2.2% | ¥7,116.00 | ¥7,288.00 | ¥7,109.00 | 2,624,300 | |
| ¥7,266.00 | +60.00 | +0.8% | ¥7,156.00 | ¥7,334.00 | ¥7,114.00 | 1,809,600 | |
| ¥7,206.00 | -134.00 | -1.8% | ¥7,230.00 | ¥7,308.00 | ¥7,138.00 | 1,907,800 | |
| ¥7,340.00 | -40.00 | -0.5% | ¥7,379.00 | ¥7,506.00 | ¥7,302.00 | 2,679,300 | |
| ¥7,380.00 | +199.00 | +2.8% | ¥7,261.00 | ¥7,444.00 | ¥7,261.00 | 2,784,700 | |
| ¥7,181.00 | +33.00 | +0.5% | ¥7,084.00 | ¥7,230.00 | ¥7,084.00 | 2,047,000 | |
| ¥7,148.00 | +2.00 | 0.0% | ¥7,080.00 | ¥7,209.00 | ¥7,011.00 | 2,423,700 | |
| ¥7,146.00 | -16.00 | -0.2% | ¥7,185.00 | ¥7,282.00 | ¥7,110.00 | 3,042,200 | |
| ¥7,162.00 | -23.00 | -0.3% | ¥7,243.00 | ¥7,245.00 | ¥7,127.00 | 2,455,900 | |
| ¥7,185.00 | +379.00 | +5.6% | ¥7,059.00 | ¥7,234.00 | ¥6,991.00 | 3,139,300 | |
| ¥6,806.00 | -384.00 | -5.3% | ¥7,040.00 | ¥7,100.00 | ¥6,700.00 | 5,246,700 | |
| ¥7,190.00 | +295.00 | +4.3% | ¥7,203.00 | ¥7,381.00 | ¥7,162.00 | 4,737,600 | |
| ¥6,895.00 | +52.00 | +0.8% | ¥6,727.00 | ¥6,922.00 | ¥6,718.00 | 3,837,300 | |
| ¥6,843.00 | +21.00 | +0.3% | ¥6,852.00 | ¥6,922.00 | ¥6,792.00 | 3,195,800 | |
| ¥6,822.00 | +169.00 | +2.5% | ¥6,684.00 | ¥6,828.00 | ¥6,667.00 | 3,076,400 | |
| ¥6,653.00 | +39.00 | +0.6% | ¥6,637.00 | ¥6,660.00 | ¥6,522.00 | 4,547,300 | |
| ¥6,614.00 | -74.00 | -1.1% | ¥6,788.00 | ¥6,844.00 | ¥6,614.00 | 3,542,700 | |
| ¥6,688.00 | -209.00 | -3.0% | ¥6,797.00 | ¥6,818.00 | ¥6,651.00 | 3,220,000 | |
| ¥6,897.00 | +102.00 | +1.5% | ¥6,774.00 | ¥6,897.00 | ¥6,695.00 | 3,324,200 | |
| ¥6,795.00 | +181.00 | +2.7% | ¥6,773.00 | ¥6,888.00 | ¥6,710.00 | 5,542,700 | |
| ¥6,614.00 | +103.00 | +1.6% | ¥6,490.00 | ¥6,645.00 | ¥6,482.00 | 2,663,400 | |
| ¥6,511.00 | +81.00 | +1.3% | ¥6,500.00 | ¥6,557.00 | ¥6,445.00 | 3,356,000 | |
| ¥6,430.00 | +96.00 | +1.5% | ¥6,365.00 | ¥6,430.00 | ¥6,295.00 | 2,458,600 | |
| ¥6,334.00 | -19.00 | -0.3% | ¥6,416.00 | ¥6,438.00 | ¥6,269.00 | 2,363,000 | |
| ¥6,353.00 | +86.00 | +1.4% | ¥6,400.00 | ¥6,429.00 | ¥6,327.00 | 2,895,600 | |
| ¥6,267.00 | +227.00 | +3.8% | ¥6,140.00 | ¥6,285.00 | ¥6,099.00 | 5,201,400 | |
| ¥6,040.00 | -130.00 | -2.1% | ¥6,100.00 | ¥6,106.00 | ¥6,036.00 | 2,360,400 | |
| ¥6,170.00 | +151.00 | +2.5% | ¥6,100.00 | ¥6,170.00 | ¥6,078.00 | 2,644,000 | |
| ¥6,019.00 | -88.00 | -1.4% | ¥6,007.00 | ¥6,040.00 | ¥5,979.00 | 3,116,800 | |
| ¥6,107.00 | +6.00 | +0.1% | ¥6,181.00 | ¥6,188.00 | ¥6,046.00 | 2,134,700 | |
| ¥6,101.00 | -19.00 | -0.3% | ¥6,126.00 | ¥6,192.00 | ¥6,070.00 | 2,228,700 | |
| ¥6,120.00 | +31.00 | +0.5% | ¥6,118.00 | ¥6,148.00 | ¥6,039.00 | 2,432,600 | |
| ¥6,089.00 | +57.00 | +0.9% | ¥6,002.00 | ¥6,137.00 | ¥6,002.00 | 3,878,500 | |
| ¥6,032.00 | -143.00 | -2.3% | ¥6,027.00 | ¥6,068.00 | ¥5,974.00 | 4,546,000 | |
| ¥6,175.00 | -50.00 | -0.8% | ¥6,159.00 | ¥6,194.00 | ¥6,002.00 | 4,383,000 | |
| ¥6,225.00 | +129.00 | +2.1% | ¥6,097.00 | ¥6,246.00 | ¥6,050.00 | 9,460,400 | |
| ¥6,096.00 | -266.00 | -4.2% | ¥6,300.00 | ¥6,340.00 | ¥6,086.00 | 4,741,300 | |
| ¥6,362.00 | -254.00 | -3.8% | ¥6,501.00 | ¥6,513.00 | ¥6,362.00 | 4,151,800 | |
| ¥6,616.00 | -34.00 | -0.5% | ¥6,706.00 | ¥6,724.00 | ¥6,595.00 | 3,185,400 | |
| ¥6,650.00 | -96.00 | -1.4% | ¥6,799.00 | ¥6,804.00 | ¥6,612.00 | 3,129,700 | |
| ¥6,746.00 | +62.00 | +0.9% | ¥6,700.00 | ¥6,755.00 | ¥6,659.00 | 2,850,900 | |
| ¥6,684.00 | +238.00 | +3.7% | ¥6,564.00 | ¥6,685.00 | ¥6,564.00 | 2,511,600 | |
| ¥6,446.00 | -54.00 | -0.8% | ¥6,470.00 | ¥6,492.00 | ¥6,396.00 | 2,225,200 | |
| ¥6,500.00 | +86.00 | +1.3% | ¥6,510.00 | ¥6,533.00 | ¥6,465.00 | 1,907,400 | |
| ¥6,414.00 | -8.00 | -0.1% | ¥6,415.00 | ¥6,442.00 | ¥6,352.00 | 1,755,500 | |
| ¥6,422.00 | +4.00 | +0.1% | ¥6,293.00 | ¥6,433.00 | ¥6,293.00 | 3,008,400 | |
| ¥6,418.00 | -58.00 | -0.9% | ¥6,418.00 | ¥6,450.00 | ¥6,310.00 | 3,141,500 | |
| ¥6,476.00 | -56.00 | -0.9% | ¥6,503.00 | ¥6,579.00 | ¥6,476.00 | 2,871,600 | |
| ¥6,532.00 | -32.00 | -0.5% | ¥6,544.00 | ¥6,570.00 | ¥6,503.00 | 2,083,000 | |
| ¥6,564.00 | -231.00 | -3.4% | ¥6,597.00 | ¥6,720.00 | ¥6,564.00 | 3,444,800 | |
| ¥6,795.00 | -83.00 | -1.2% | ¥6,818.00 | ¥6,873.00 | ¥6,794.00 | 1,920,500 | |
| ¥6,878.00 | +46.00 | +0.7% | ¥6,868.00 | ¥6,878.00 | ¥6,777.00 | 2,283,900 | |
| ¥6,832.00 | -102.00 | -1.5% | ¥6,900.00 | ¥6,951.00 | ¥6,814.00 | 2,345,900 | |
| ¥6,934.00 | +21.00 | +0.3% | ¥6,910.00 | ¥6,976.00 | ¥6,904.00 | 1,623,100 | |
| ¥6,913.00 | -120.00 | -1.7% | ¥6,883.00 | ¥6,953.00 | ¥6,855.00 | 2,937,400 | |
| ¥7,033.00 | +86.00 | +1.2% | ¥6,999.00 | ¥7,054.00 | ¥6,958.00 | 1,982,400 | |
| ¥6,947.00 | -104.00 | -1.5% | ¥7,015.00 | ¥7,044.00 | ¥6,920.00 | 1,806,300 | |
| ¥7,051.00 | +101.00 | +1.5% | ¥7,028.00 | ¥7,090.00 | ¥7,000.00 | 1,503,700 | |
| ¥6,950.00 | -37.00 | -0.5% | ¥6,914.00 | ¥6,983.00 | ¥6,902.00 | 1,301,800 | |
| ¥6,987.00 | -24.00 | -0.3% | ¥7,030.00 | ¥7,130.00 | ¥6,966.00 | 1,196,300 | |
| ¥7,011.00 | -90.00 | -1.3% | ¥7,019.00 | ¥7,111.00 | ¥6,996.00 | 1,887,500 | |
| ¥7,101.00 | +216.00 | +3.1% | ¥6,985.00 | ¥7,141.00 | ¥6,974.00 | 2,536,300 |
- Ticker
- Tradegate:CUP
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- Tradegate
- Currency
- EUR
What changed lately
Latest news release · Oct 27, 2026
Supplementary Materials Consolidated Financial Statements for the nine months ended September 30, 2026 (IFRS)
Latest earnings call · Jul 24, 2026
Chugai Pharmaceutical (Tokyo:4519) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Oct 27, 2026
Q3 2026 Earnings Presentation
Earnings · 32 slides
Latest news
Supplementary Materials Consolidated Financial Statements for the nine months ended September 30, 2026 (IFRS)
Oct 27, 2026
Closed ¥6,614.00 (-1.1%) on Oct 28, 2026
CONSOLIDATED FINANCIAL STATEMENTS (IFRS) (Non-Audited) (for the nine months ended September 30, 2026)
Oct 27, 2026
Closed ¥6,614.00 (-1.1%) on Oct 28, 2026
F. Hoffmann-La Roche Announces Third Quarter Sales 2026
Oct 22, 2026
Closed ¥6,614.00 (+1.6%) on Oct 22, 2026
Notice Regarding Discontinuation of Development of GYM329 (emugrobart) for Obesity, Return of License and Resumption of Development for SMA
Sep 28, 2026
Closed ¥6,096.00 (-4.2%) on Sep 29, 2026
Three Chugai Researchers Behind the Discovery of Hemlibra for Hemophilia A Receive Prestigious U.S. Lasker Award, One of the World’s Most Respected Scientific Honors
Sep 9, 2026
Closed ¥6,418.00 (-0.9%) on Sep 10, 2026
Chugai and GSK Sign Exclusive License Agreement for Anti-Dengue Virus Antibody AID351
Aug 18, 2026
Closed ¥6,885.00 (+0.6%) on Aug 19, 2026
Chugai Announces 2026 2nd Quarter Results
Jul 27, 2026
Closed ¥6,999.00 (+2.2%) on Jul 28, 2026
CONSOLIDATED FINANCIAL STATEMENTS (IFRS) (Non-Audited) (for the six months ended June 30, 2026)
Jul 24, 2026
Closed ¥6,848.00 (-7.7%) on Jul 27, 2026
F. Hoffmann-La Roche Announces Half Year Results 2026
Jul 23, 2026
Closed ¥7,212.00 (-1.3%) on Jul 23, 2026
Chugai Pharmaceutical Co., Ltd. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 25 in the last 12 months · 31 in all · newest Oct 27, 2026 · oldest 2025
- Calls
- 9 calls with a replay · 9 with a transcript · latest Jul 24, 2026
- Decks
- 107 decks · latest Oct 27, 2026
Where Chugai Pharmaceutical Co., Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Tokyo:4519 中外製薬 · Home listing | Tokyo | Japan | JPY |
| OTC:CHGCY | OTC | United States | USD |
| OTC:CHGCF | OTC | United States | USD |
| gettex:CUP | gettex | Germany | EUR |
| Frankfurt:CUP | Frankfurt | Germany | EUR |
| Tradegate:CUP · This page | Tradegate | Germany | EUR |
| LS Exchange:857216 | LS Exchange | Germany | EUR |
| Lang & Schwarz:857216 | Lang & Schwarz | Germany | EUR |
| BMV:4519N | BMV | Mexico | MXN |
| Munich:CUP | Munich | Germany | EUR |
| Stuttgart:CUP | Stuttgart | Germany | EUR |
| Hamburg:CUP | Hamburg | Germany | EUR |
| Dusseldorf:CUP | Dusseldorf | Germany | EUR |
| gettex:CUP0 | gettex | Germany | EUR |
| Hanover:CUP | Hanover | Germany | EUR |
| BIVA:4519N | BIVA | Mexico | MXN |
| Frankfurt:CUP0 | Frankfurt | Germany | EUR |
| Munich:CUP0 | Munich | Germany | EUR |
Team and board
Officers
| Officer | Role |
|---|---|
| Osamu Okuda | Representative Director, President & CEO |
| Iwaaki Taniguchi | Director, Executive Vice President & CFO |
| Hitoshi Iikura | Director, Executive Vice President |
| Boris L. Zaïtra | Head of Corporate Business Development of Roche |
Board
| Director | Role |
|---|---|
| Boris L. Zaïtra | Head of Corporate Business Development of Roche |
| Hitoshi Iikura | Director, Executive Vice President |
| Iwaaki Taniguchi | Director, Executive Vice President & CFO |
| Masayoshi Higuchi | Audit & Supervisory Board Member (full-time) |
| Osamu Okuda | Representative Director, President & CEO |
| Shigehiro Yamada | Audit & Supervisory Board Member (full-time) |
| Teresa A. Graham | Director |
| Thomas Schinecker | Director |
Events
| Call | When | Status |
|---|---|---|
| Chugai Pharmaceutical (Tokyo:4519) Q2 2026 Earnings Call | Fri, Jul 24, 2026 · 3:00 AM ET | Replay |
| Chugai Pharmaceutical (Tokyo:4519) Q1 2026 Earnings Call | Fri, Apr 24, 2026 · 5:00 AM ET | Replay |
| Chugai Pharmaceutical (Tokyo:4519) Q4 2025 Earnings Call | Thu, Jan 29, 2026 · 3:30 AM ET | Replay |
| Chugai Pharmaceutical (Tokyo:4519) Q3 2025 Earnings Call | Sat, Oct 25, 2025 · 5:00 AM ET | Replay |
| Chugai Pharmaceutical (Tokyo:4519) Q2 2025 Earnings Call | Thu, Jul 24, 2025 · 4:00 AM ET | Replay |
| Chugai Pharmaceutical (Tokyo:4519) Q4 2024 Earnings Call | Thu, Jan 30, 2025 · 3:30 AM ET | Replay |
| Chugai Pharmaceutical (Tokyo:4519) Q3 2024 Earnings Call | Fri, Oct 25, 2024 · 5:00 AM ET | Replay |
| Chugai Pharmaceutical (Tokyo:4519) Q2 2024 Earnings Call | Wed, Jul 24, 2024 · 4:00 AM ET | Replay |
| Chugai Pharmaceutical (Tokyo:4519) Q1 2024 Earnings Call | Wed, Apr 24, 2024 · 5:00 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2026 Earnings Presentation | Earnings | 32 slides | Oct 27, 2026 |
| Q3 2026 Earnings Presentation | Earnings | 32 slides | Oct 27, 2026 |
| Q2 2026 Earnings Presentation | Earnings | 34 slides | Jul 24, 2026 |
| Q2 2026 Earnings Presentation | Earnings | 34 slides | Jul 24, 2026 |
| Technical Presentation (June 2026) | Technical | 45 slides | Jun 17, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 34 slides | Apr 24, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 53 slides | Jan 29, 2026 |
| Q2 2025 Earnings Presentation | Earnings | 47 slides | Jul 24, 2025 |
| souzoulabo slide | 6 slides | February 2025 | |
| FY2024 Earnings Presentation | Earnings | 56 slides | Jan 30, 2025 |
Show 50 decks
This page holds 50 of 107 decks. Open Decks
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| CONSOLIDATED FINANCIAL STATEMENTS (IFRS) (Non-Audited) (for the nine months ended September 30, 2026) | Oct 27, 2026 | Results | Tokyo Stock Exchange |
| Supplementary Materials Consolidated Financial Statements for the nine months ended September 30, 2026 (IFRS) | Oct 27, 2026 | Results | Tokyo Stock Exchange |
| F. Hoffmann-La Roche Announces Third Quarter Sales 2026 | Oct 22, 2026 | Other filings | Tokyo Stock Exchange |
| Notice Regarding Discontinuation of Development of GYM329 (emugrobart) for Obesity, Return of License and Resumption of Development for SMA | Sep 28, 2026 | Other filings | Tokyo Stock Exchange |
| CONSOLIDATED FINANCIAL STATEMENTS (IFRS) (Non-Audited) (for the six months ended June 30, 2026) | Jul 24, 2026 | Interim report | Tokyo Stock Exchange |
| F. Hoffmann-La Roche Announces Half Year Results 2026 | Jul 23, 2026 | Interim report | Tokyo Stock Exchange |
Cap table
Built by 6ix from Chugai Pharmaceutical Co., Ltd.’s releases
- Common shares
- 1,679,057,667
- Fully diluted
- 1,679,057,667
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 1,679,057,667 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 1,679,057,667 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Boris L. Zaïtra | Head of Corporate Business Development of Roche · Since at least Mar 27, 2026 |
| Hitoshi Iikura | Director, Executive Vice President · Since at least Mar 27, 2026 |
| Iwaaki Taniguchi | Director, Executive Vice President & CFO · Since at least Mar 27, 2026 |
| Masayoshi Higuchi | Audit & Supervisory Board Member (full-time) · Since at least Nov 5, 2026 |
| Osamu Okuda | Representative Director, President & CEO · Since at least Sep 9, 2026 |
| Shigehiro Yamada | Audit & Supervisory Board Member (full-time) · Since at least Nov 5, 2026 |
| Teresa A. Graham | Director · Since at least Mar 27, 2026 |
| Thomas Schinecker | Director · Since at least Mar 27, 2026 |
Log in to ask 6ix AI your own questions about Chugai Pharmaceutical Co., Ltd.